THE NICKLES GROUP, LLC for CSL BEHRING LLC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to gene therapy. Issues related to plasma therapies. Monitored issues related to value based payment arrangements. Monitored implementation of H.R. 5376 (P.L. 117-169), the Inflation Reduction Act, as it relates to plasma derived products and drug pricing.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Health Issues HCR
Monitored issues related to the medical supply chain. S. 4348, FDASLA Act of 2022 and H.R. 7667, Food and Drug Amendment of 2022, including issues related to PDUFA and accelerated approval pathways. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023, as it relates to the FDA including modernizing accelerated approval and clinical trial diversity.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Taxation/Internal Revenue Code TAX
H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023, as it relates to amortization of R&D expenses. Monitored H.R. 1304, the American Innovation and R&D Competitiveness Act; and S. 749, the American Innovation and Jobs Act; and issues related to the R&D tax credit.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL JONES HENSLER | — |
Homeland Security HOM
Monitored issues related to plasma donation.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD KENT | — |
| MARY BETH SAVARY TAYLOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.